TTM
−$0.97
YoY change
-80.6%
5Y CAGR
—
Peak year (2013)
−$0.22
Latest annual
−$1.14
EPS (Diluted) history chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: −$1.14
EPS (Diluted) growth chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: -80.6%
EPS (Diluted) history table for Teladoc Health (TDOC) from 2013 to 2025
| 2025 | −$1.14 | -80.6% | +$4.73 | ||
| 2024 | −$5.87 | +338.1% | −$4.53 | ||
| 2023 | −$1.34 | -98.4% | +$83.26 | ||
| 2022 | −$84.60 | +2998.9% | −$81.87 | ||
| 2021 | −$2.73 | -49.1% | +$2.63 | ||
| 2020 | −$5.36 | +288.4% | −$3.98 | ||
| 2019 | −$1.38 | -6.1% | +$0.09 | ||
| 2018 | −$1.47 | -23.8% | +$0.46 | ||
| 2017 | −$1.93 | +10.3% | −$0.18 | ||
| 2016 | −$1.75 | -39.9% | +$1.16 | ||
| 2015 | −$2.91 | +369.4% | −$2.29 | ||
| 2014 | −$0.62 | +181.8% | −$0.40 | ||
| 2013 | −$0.22 | — | — |
- 2025−$1.14-80.6%
- 2024−$5.87+338.1%
- 2023−$1.34-98.4%
- 2022−$84.60+2998.9%
- 2021−$2.73-49.1%
- 2020−$5.36+288.4%
- 2019−$1.38-6.1%
- 2018−$1.47-23.8%
- 2017−$1.93+10.3%
- 2016−$1.75-39.9%
- 2015−$2.91+369.4%
- 2014−$0.62+181.8%
- 2013−$0.22—
EPS (Diluted) values are taken from Teladoc Health's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Teladoc Health (TDOC)
According to Teladoc Health's latest reported financial statements, the company's current diluted EPS (TTM) is −$0.97. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Teladoc Health (TDOC) most recent annual diluted EPS stands at −$1.14 (2025) – plunged 80.6% year-over-year.
The highest annual diluted EPS of −$0.22 was reported in 2013. The lowest in the available history was −$84.60 in 2022.
Teladoc Health EPS (Diluted) by Year
Teladoc Health EPS (Diluted) 2025: −$1.14
2025's diluted EPS for Teladoc Health came in at −$1.14, plunged 80.6% below 2024.
Teladoc Health EPS (Diluted) 2024: −$5.87
Teladoc Health posted diluted EPS of −$5.87 in 2024, surged 338.1% from 2023.
Teladoc Health EPS (Diluted) 2023: −$1.34
In 2023, Teladoc Health reported diluted EPS of −$1.34, plunged 98.4% below 2022.
Teladoc Health EPS (Diluted) 2022: −$84.60
Teladoc Health diluted EPS in 2022 was −$84.60, surged 2998.9% from 2021. This figure represents the lowest annual value in the available history.
Teladoc Health EPS (Diluted) 2021: −$2.73
Teladoc Health diluted EPS in 2021 was −$2.73.
See more financial history for Teladoc Health (TDOC). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Teladoc Health (TDOC), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation